Balrampur Chini Mills Limited Overview
Balrampur Chini Mills is one of India's two largest integrated sugar producers and the largest by crushing capacity among listed Uttar Pradesh players, operating ten sugar complexes with 80,000 tonnes of cane per day (TCD), 1,050 kilolitres per day (KLPD) of distillery capacity at five sites and about 175.7 MW of saleable co-generation capacity. Its operating model maximises value from each tonne of cane: sucrose is split between sugar and ethanol depending on relative policy-set economics, bagasse fuels power export, and molasses and grain feed the distilleries. FY2026 revenue was ₹6,271 Cr. The company is now executing the most significant pivot in its history: an 80,000 tonnes-per-annum polylactic acid (PLA) bioplastics plant at Kumbhi, the first industrial-scale PLA facility in India, at a revised capex of about ₹3,080 Cr, targeted for commissioning in Q3 FY2027. Management's ambition is for non-sugar "green" revenues to reach about half of total revenue within roughly three years of PLA ramp-up.
What the company does
BCML converts sugarcane procured from roughly the eastern and central Uttar Pradesh cane belt into four product streams:
-
Sugar — white crystal sugar sold primarily to bulk/institutional buyers and traders in the domestic market, subject to government-set monthly release quotas. A small share is exported when export policy permits.
-
Distillery products — fuel ethanol sold to oil marketing companies (OMCs) under the Ethanol Blended Petrol (EBP) programme, produced from B-heavy molasses, cane juice/syrup and, increasingly, grain (FCI rice/maize); plus extra-neutral alcohol and industrial alcohol in smaller volumes.
-
Co-generation power — electricity produced from bagasse, consumed captively and exported to the Uttar Pradesh grid under power purchase arrangements. In BCML's segment reporting, co-generation is embedded within the Sugar segment.
-
Polylactic acid (PLA) bioplastics — a new segment from FY2026, currently seeding the market with imported resin and finished compostable products under the "Balrampur Bioyug" brand ahead of the Kumbhi plant commissioning.
Minor "Others" include agricultural inputs (fertiliser/soil conditioners derived from press mud and ash) and miscellaneous items.
Company's own description
In its corporate materials, BCML describes itself as one of the largest integrated sugar companies in India, with allied businesses in distillery operations and co-generation of power, and as one of the most efficient integrated sugar producers in the country, having grown through planned capacity expansion and acquisitions. The investor-relations pages describe the company as the second-largest sugar manufacturer in India and frame the strategic narrative as a transition from a sugar company to an energy and bio-materials company. Management's recurring philosophy, articulated in the Q4 FY25 commentary, is to extract the maximum value from every stick of cane.
Revenue model
| Revenue stream | Model | Pricing determinant | FY26 gross segment revenue (INR Cr) |
|---|---|---|---|
| Sugar (incl. co-gen power) | Product sale, B2B | Domestic market price constrained by Minimum Selling Price (MSP) floor, monthly release quotas, export policy | 5,507.23 |
| Distillery | Product sale under OMC tenders/allocations | Government-administered ethanol procurement prices by feedstock route | 1,720.97 |
| PLA | Product sale (resin trading and compostable products at present) | Market price, premium to fossil plastics | 23.88 |
| Others | Product sale | Market | 13.90 |
| Less: inter-segment eliminations | Molasses/syrup and power transferred internally | — | approx. 995 (derived) |
| Revenue from operations | — | — | 6,271.15 |
Source: FY2026 audited consolidated segment results (15 May 2026). Inter-segment elimination is derived as the difference between the sum of segments and reported revenue.
There is no subscription or licensing revenue; BCML is a 100% physical product business.
Value chain position
BCML sits at the processing node of an agro-industrial chain: farmers (cane supply, at state-advised prices) → BCML mills (crushing, crystallisation, distillation, co-generation) → bulk buyers (FMCG, beverage, confectionery companies, traders), OMCs (ethanol), the UP grid (power), and, prospectively, converters of bioplastic film, packaging and foodservice disposables (PLA). Its cost base is dominated by cane procurement at the Uttar Pradesh State Advised Price (SAP), which rose from ₹370 to ₹400 per quintal for SS 2025-26 (Q4 FY26 earnings call), giving the company limited control over its single largest input cost.
Customer types and end-markets
| End-market | Customer type | Key characteristic |
|---|---|---|
| Domestic sugar (household and industrial) | Traders, FMCG, beverage, confectionery, pharma | Government quota-regulated releases |
| Fuel ethanol | OMCs (IOCL, BPCL, HPCL) | Administered prices; 20% blending achieved nationally |
| Power | UP state distribution utilities | Long-term tariff arrangements |
| Bioplastics | Converters, institutions, packaging users | Early-stage; first institutional order from Lucknow Cantonment Board |
| Agri inputs | Farmers in command area | Small, relationship-based |
Independent characterisation
BCML is best understood as a policy-exposed commodity converter with an unusually strong balance sheet for its sector, now making a concentrated, technology-intensive bet on a non-cyclical, non-administered product (PLA). Its earnings in the core business are effectively a function of four policy variables — SAP cane price, sugar MSP/release quota, export permission and ethanol procurement prices — overlaid on agro-climatic cane availability and recovery. The PLA project changes the risk profile from regulatory/agricultural to technological/market-adoption risk.
Strategy
Stated strategic themes (paraphrased from FY2026 communications)
-
Value maximisation per tonne of cane — flexible diversion of sucrose between sugar and ethanol based on relative economics.
-
Transformation into a green energy and bio-materials company — the IR site frames BCML as moving from a sugar company towards an energy company; PLA extends this into materials.
-
Revenue diversification — management targets non-sugar/green businesses (ethanol, co-gen, PLA) reaching about 50% of revenue within three years of the PLA plant running at full capacity (Avantika Saraogi; previously expressed as FY2027–28). Non-sugar businesses were about 20% of revenue at the time of the Feb 2025 foundation-stone event.
-
Operational efficiency and cane development — management expects improved yields from new cane varieties (FY2026 commentary).
-
Balance-sheet prudence — PLA funded with a 40:60 equity:debt structure and fresh equity to protect ratings.
Initiatives in the last 24 months
| Date | Initiative | Details | Status |
|---|---|---|---|
| 2,024 | UP Bioplastic Industrial Policy 2024 alignment | Capital subsidy reducing PLA net capex to ~₹1,750 Cr (on ₹2,850 Cr gross) | Utilisation-linked incentives |
| Feb 2025 | PLA foundation stone | Kumbhi; ₹2,850 Cr; 80,000 TPA | Construction completed in phases |
| FY2026 | Year-round distillery operation via grain route | Grain ethanol production up from 1.73 to 4.75 Cr BL | Ongoing |
| FY2026 | PLA segment created; imported-resin market seeding | Business development, samples | Ongoing |
| 23 Apr 2026 | Capital raise and capex revision | ₹450 Cr preferential equity; ₹200 Cr NCDs; PLA capex to ₹3,080 Cr; ₹160 Cr lactogypsum plant | Equity completed 3 Jun 2026 |
| 28 Apr 2026 | Investor call on PLA project | Revised capex and funding explained | Completed |
| 27 May 2026 | Launch of Balrampur Bioyug as India's first PLA biopolymer brand | Exchange press release | Completed |
| 5 Jun 2026 | Bioyug Green Command 2026 | Bioplastics adoption campaign (World Environment Day) | Ongoing |
| 2,026 | Pan masala/gutka PLA multi-layer film | Working with stakeholders to replace conventional sachets | Development |
| 2,026 | Lucknow Cantonment Board order | First institutional PLA order | Delivered/ongoing |
| Oct 2026 (target) | PLA commissioning | Q3 FY2027 | In progress |
Medium-term targets and guidance
| Target | Value | Source / status |
|---|---|---|
| PLA commissioning | Q3 FY2027 (October 2026) | Company, reiterated Q4 FY26 and Q1 FY27 |
| PLA revised capex | ~₹3,080 Cr | Company |
| Non-sugar revenue share | ~50% within ~3 years of full PLA operation | Management statements |
| PLA peak revenue / EBITDA margin | ~₹2,000 Cr / ~35% | Media report of management commentary; not formal guidance |
| FY2027 PLA-related debt | Up to ~₹1,500 Cr limit | CompoundingAI preview citing company |
BCML does not issue formal revenue/EPS guidance for the core business.
Products & Services
Sugar segment
| Product | Description | Specifications / capacity | Target customer | Pricing |
|---|---|---|---|---|
| White crystal sugar (S-30/M-30 grades typical for UP mills) | Plantation white/refined sugar | Ten units, 80,000 TCD aggregate | Bulk FMCG, beverage, confectionery buyers, traders | Market price above government MSP; FY26 average blended realisation ₹40.7/kg; Q4 FY26 ₹40.83/kg; Q1 FY27 ₹41.55/kg |
| Export sugar | White sugar under export quota when permitted | Subject to DGFT policy | International buyers | FOB; exports prohibited from 13 May to 30 Sep 2026 |
| Molasses | By-product; largely transferred to distilleries | — | Internal | Transfer price |
| Bagasse | By-product; fuels co-gen boilers | — | Internal | — |
| Co-generation power | Bagasse-fired steam/power | Approx. 175.7 MW saleable across 6 co-gen units | UP grid / captive | Regulated tariff |
Operational metrics, SS 2025-26 (Q4 FY26 call): cane crushed about 1,043 lakh quintals (+5.2% YoY, while Uttar Pradesh as a whole crushed about 7% less); gross recovery before diversion 11.24% vs 11.28% prior season. Q4 FY26 sugar sales were 21.42 lakh quintals (vs 19.95). Q1 FY27 sugar sales were 24.49 lakh quintals.
Distillery segment
| Product | Feedstock route | FY2025 | FY2026 | Customer |
|---|---|---|---|---|
| Fuel ethanol | B-heavy molasses (production, crore bulk litres) | 7.20 | 9.66 | OMCs |
| Fuel ethanol | Grain route (production, crore bulk litres) | 1.73 | 4.75 | OMCs |
| Fuel ethanol | Syrup/juice route | not disclosed (Q3 FY26: 2.91 Cr BL) | — | OMCs |
| Total ethanol sales (crore bulk litres) | — | 23.44 | 26.56 | OMCs |
| ENA / industrial alcohol | C-heavy molasses/grain | — | — | Potable alcohol and chemical industries |
Capacity: 1,050 KLPD across five distilleries (Balrampur, Babhnan, Mankapur, Gularia, Maizapur). Gularia operates at 200 KLPD; Maizapur was configured for full sucrose diversion (no sugar production) from SS 2022-23. Grain capability enables year-round operation; the government allowed 52 lakh tonnes of FCI rice to be sold at ₹23.20/kg for ethanol in ESY 2025-26 (Q3 FY26 presentation).
PLA segment — Balrampur Bioyug
| Element | Detail | Source |
|---|---|---|
| Brand | Balrampur Bioyug (brand launch announced to exchanges 27 May 2026) | Finology exchange feed |
| Plant | Kumbhi, Gola Gokarannath, Lakhimpur Kheri, adjacent to the Kumbhi sugar unit | ChemIndigest/IBEF |
| Capacity | 80,000 tonnes per annum PLA | Company |
| Process | Sugarcane-derived sugars → lactic acid → lactide → PLA, single integrated site; PLA technology from Sulzer | European Bioplastics interview |
| Energy and water | 100% renewable power (bagasse co-gen); zero liquid discharge | European Bioplastics; Drishti IAS |
| Environmental claim | Production emits about 68% less GHG than conventional plastics (company claim) | European Bioplastics interview |
| Capex | Originally ₹2,000 Cr (reported), then ₹2,850 Cr gross / ~₹1,750 Cr net of UP capital subsidy; revised to ~₹3,080 Cr (April 2026) | Q4 FY25 commentary; FY26 results |
| Spend to date | ~₹2,180 Cr as of 31 July 2026 | Q1 FY27 presentation |
| Financing | Approx. 40% equity / 60% debt; PLA long-term borrowings ₹1,086 Cr at 30 Jun 2026 | Swarajya; Q1 FY27 presentation |
| Commissioning | Q3 FY2027 (October 2026 target) | Company guidance |
| Peak potential | Reported target of ~₹2,000 Cr revenue at ~35% EBITDA margin at full utilisation (media report of management commentary; not in audited filings) | Whalesbook, Feb 2026 |
| Current products | Imported PLA resin (trading); compostable garbage bags, bottles, pens, cups, plates, cutlery, carry bags | Swarajya; ChiniMandi |
| First institutional order | Lucknow Cantonment Board (compostable garbage bags, bottles, pens) | Swarajya, Aug 2026 |
| Application development | PLA-based multi-layer film to replace conventional pan masala/gutka sachet packaging | Chemical Weekly, May 2026 |
| Market-seeding campaign | "Bioyug Green Command 2026", launched 5 June 2026 | Sahi news summary |
| Leadership | Stefan Barot, President – Chemical Division (PLA) | European Bioplastics |
Lactogypsum board project (PLA by-product)
The Board approved a lactogypsum processing plant at Kumbhi with capex up to ₹160 Cr and capacity of about 76 lakh gypsum boards per annum, converting the gypsum by-product of lactic acid purification into saleable building boards (approved 23 April 2026).
Others
Agricultural inputs (press-mud/ash-based soil nutrients and fertiliser) and miscellaneous sales: FY2026 revenue ₹13.90 Cr. Individual product brands are not publicly disclosed.
Financial Narrative
Income statement (consolidated)
Sources: Revenue and expenditure — Anand Rathi financials (company-sourced, FY2022–FY2026); EBITDA derived as revenue less expenditure (FY2025 ₹704 Cr and FY2026 ₹741 Cr match company/analyst reported EBITDA). FY2026 and FY2025 PBT and PAT — company results releases. Standalone PAT FY2024/FY2025 — Torus Digital; FY2026 — company directors' commentary (₹34,721.74 lakh).
Margins and growth
Computed; FY2022 growth vs FY2021 revenue of ₹4,811.66 Cr. Gross margin per Craytheon (FY2024–FY2025). Four-year revenue CAGR FY2022–FY2026: 6.7% (computed). Ten-year CAGR to FY2025 reported by Craytheon: 6.1%.
Per-share data
Sources: FY2024–FY2025 EPS from Craytheon (filings-based); FY2026 EPS computed as ₹378.46 Cr ÷ ~20.2 Cr weighted shares (approximate — confirm with annual report); FY2023 DPS from 47th AGM notice (interim ₹2.50 confirmed as final); FY2025 DPS from Equitymaster and Quartr summary (₹3.00); FY2026 interim ₹3.50 per share (record date 17 Nov 2025, outflow ~₹70.68 Cr).
Quarterly trajectory (consolidated)
Sources: Q1 FY26 ₹51.57 Cr, Q2 FY26 ₹53.89 Cr (Kotak Neo consolidated; 5paisa shows ₹44.63 Cr, likely standalone), Q4 FY26 ₹159.57 Cr (Screener), Q1 FY27 ₹44.14 Cr (PTI). Q3 FY26 PAT of ~₹113 Cr is derived as the residual of the FY26 total and should be checked. Q1 FY27 EBITDA margin was 6.96% (−174 bps YoY), EPS ₹2.16, finance cost ₹32.48 Cr (−3.53% YoY).
Seasonality is pronounced: Q4 (January–March) is the peak crushing quarter and typically carries the bulk of annual profit (Q4 FY25 PAT ₹229.12 Cr; Q4 FY26 ₹159.57 Cr).
Balance sheet
Sources: FY2026 net worth ₹3,839.30 Cr (+8.82%) and capital employed ₹5,142.29 Cr (+18.23%) per FY26 directors' commentary; FY2025 values back-calculated from those growth rates. Craytheon shows FY2025 net worth ₹3,796 Cr and total assets ₹7,129 Cr — the gap to the company-derived ₹3,528 Cr likely reflects consolidated vs standalone basis; both are shown. Long-term borrowings at 31 March 2026: ₹97.50 Cr existing business, ₹903.00 Cr PLA. At 30 June 2026: ₹75.25 Cr and ₹1,086.00 Cr respectively, after ₹183 Cr PLA drawdown and ₹22.25 Cr repayment. Post-period, ₹450 Cr of preferential equity was added in June 2026.
Cash flow
Sources: Craytheon reports FY2025 FCF of −₹467 Cr, driven by PLA capex, with operating cash flow below net income. FY2026 dividend outflow ~₹70.68 Cr (interim ₹3.50). No buybacks since the sixth programme (FY2023).
Ratios
Sources: FY2025 per Craytheon; FY2026 ROE computed (₹378 Cr ÷ average equity ~₹3,820 Cr) and ROCE per Screener (9.28%). Screener notes a 3-year average ROE of ~11.6% and a 3-year dividend payout of ~14.3%.
Commentary on trends, inflections and drivers
Revenue. BCML's top line has oscillated rather than compounded: FY2023's dip reflected lower sugar volumes and higher diversion to ethanol; FY2024's 19.9% jump reflected volume recovery and firm realisations; FY2025's 3.2% decline reflected a 15% drop in distillery revenue as the government curbed cane-juice diversion in ESY 2023-24 amid sugar supply concerns; FY2026's 15.8% growth was broad-based, with distillery volumes rebounding 20% on grain-route production and B-heavy volumes, and sugar revenue up 12.45% on higher sales volumes and slightly higher realisations.
Margins. EBITDA margin has compressed from ~14% in FY2024 to 11.8% in FY2026 and to 6.96% in Q1 FY2027. The driver is a structural squeeze: SAP rose ~8% for SS 2025-26 while ethanol procurement prices for juice and B-heavy routes were frozen for three years, and grain ethanol carries lower margins than molasses ethanol. PLA pre-operating losses (₹16.72 Cr in FY2026) add marginal drag.
Profitability inflection. Consolidated PAT fell for the second consecutive year in FY2026 (−13.4%) despite revenue growth — a clear signal that operating leverage in the core business is currently negative under prevailing policy settings. Standalone PAT was nearly flat (+1%), so the consolidated decline partly reflects lower associate income.
Balance sheet. BCML entered the PLA build with very low leverage in the existing business (₹97.5 Cr long-term debt at March 2026). The PLA project is being funded with a mix of internal accruals, ₹450 Cr of fresh equity and project debt (₹1,086 Cr drawn by June 2026, with management referring to a PLA-related debt limit of about ₹1,500 Cr in FY2027). Capital employed rose 18% in FY2026, depressing ROCE until PLA cash flows arrive.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Products |
|---|---|---|
Sugar | Ten sugar complexes and associated co-generation units | White sugar, molasses (internal transfer), bagasse-based power |
Distillery | Five distilleries (Balrampur, Babhnan, Mankapur, Gularia, Maizapur) | Fuel ethanol (B-heavy, juice/syrup, grain routes), alcohol |
Polylactic Acid (PLA) | New segment from FY2026; pre-commissioning business development | Imported PLA resin, Bioyug compostable products |
Others | Residual activities | Agricultural inputs and miscellaneous |
Sugar | Predominant | Small, policy-dependent |
Distillery | 100% (OMC sales) | — |
PLA | Domestic seeding; export ambitions not quantified | — |
“—” = not publicly disclosed.
Segment revenue (INR Cr)
| Segment revenue (INR Cr) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Sugar | 4,709 | 4,898 | 5,507 |
Distillery | 1,682 | 1,430 | 1,721 |
PLA | 0 | 0 | 24 |
Others | — | — | 14 |
Revenue from operations (consolidated) | 5,594 | 5,415 | 6,271 |
“—” = not publicly disclosed.
Segment Margins & Growth (%) and Revenue by Segment (%)
| Metric | FY2025 | FY2026 |
|---|---|---|
Sugar revenue growth YoY (%) | 4.0 | 12.45 |
Distillery revenue growth YoY (%) | -15.0 | 20.35 |
Sugar share of gross segment revenue (%) | 77.4 | 75.8 |
Distillery share of gross segment revenue (%) | 22.6 | 23.7 |
PLA share of gross segment revenue (%) | 0 | 0.3 |
Segment profit data point
| Segment profit data point | Value | Source |
|---|---|---|
PLA segment PBIT FY2026 | Loss of ₹16.72 Cr (pre-operating costs, business development, free samples) | Q4 FY26 presentation via Multibagg |
Consolidated PBT FY2026 | ₹560.15 Cr (vs ₹562.25 Cr FY2025) | FY26 results |
Standalone PBT FY2026 | ₹523.69 Cr (vs ₹470.40 Cr FY2025, +11.33%) | FY26 results |
Q4 FY26 PBT margin | 14.72% (vs 20.73% in Q4 FY25) | Multibagg summary of results |
Segment revenue (INR Cr) (Quarterly)
| Segment revenue (INR Cr) | Q1FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|
Sugar | 1,168 | 1,616 | 1,225 |
Distillery | 461 | 501 | 540 |
PLA | 0 | 9 | 17 |
Income Statement
| Metric (INR Cr) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations | 4,846 | 4,666 | 5,594 | 5,415 | 6,271 |
Operating expenditure | 4,146 | 4,154 | 4,808 | 4,711 | 5,530 |
EBITDA (excl. other income) | 700 | 512 | 786 | 704 | 741 |
Profit before tax | — | — | — | 562 | 560 |
Net profit (consolidated PAT) | 506 | 276 | 534 | 437 | 378 |
Net profit (standalone PAT) | — | — | 433 | 344 | 347 |
Margin Analysis (%)
| Metric (%) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
EBITDA margin | 14.4 | 11.0 | 14.1 | 13.0 | 11.8 |
Net margin (consolidated) | 10.4 | 5.9 | 9.5 | 8.1 | 6.0 |
Revenue growth YoY | 0.7 | -3.7 | 19.9 | -3.2 | 15.8 |
Gross margin | — | — | 30.0 | 28.8 | — |
“—” = not publicly disclosed.
Per-Share Data
| Metric (INR per share) | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|
Diluted EPS (consolidated) | — | 26.49 | 21.57 | 18.74 |
Dividend per share | 2.50 | — | 3.00 | 3.50 |
Income Statement (Quarterly)
| Metric (INR Cr) | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|
Revenue from operations | 1,542 | 1,671 | 1,454 | 1,604 | 1,637 |
Net profit | 52 | 54 | 113 | 160 | 44 |
Balance Sheet
| Metric (INR Cr) | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Total assets | — | 7,129 | — |
Net worth (consolidated, per Craytheon) | — | 3,796 | — |
Net worth (company-reported) | — | 3,528 | 3,839 |
Capital employed | — | 4,349 | 5,142 |
Long-term borrowings — existing business | — | — | 98 |
Long-term borrowings — PLA | 0 | — | 903 |
Share capital | 20.17 | 20.19 | 20.20 |
Cash Flow
| Metric (INR Cr) | FY2025 | FY2026 |
|---|---|---|
Free cash flow | -467 | — |
Dividends paid | — | 71 |
Buybacks | 0 | 0 |
Preferential equity raised (post year-end, June 2026) | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2025 | FY2026 |
|---|---|---|
ROE (%) | 11.5 | 9.8 |
ROCE (%) | 10.2 | 9.3 |
Current ratio (x) | 1.29 | — |
Debt/equity (x) | 0.69 | — |
Interest coverage (x) | 5.7 | — |
Price Point Details
| Price point (INR) | Value |
|---|---|
12 Jan 2026 | 416.90 |
13 Mar 2026 | 486.00 |
20 Apr 2026 | 509.00 |
5 May 2026 | 526.70 |
8 Jul 2026 | 560.85 |
11 Aug 2026 | 630.25 |
28 Aug 2026 | 648.90 |
18 Sep 2026 | 677.60 |
14 Oct 2026 | 713.85 |
52-week high / low | 781.00 / 393.40 |
Return horizon | Return (%) |
6 months | 43.1 |
1 year | 33.9 |
3 years | 54.5 |
Valuation Multiples
| Multiple | BCML | Basis |
|---|---|---|
Market cap (INR Cr) | ~15,080 | 21.13 Cr shares |
P/E (FY26 consolidated EPS) | ~38x | ₹378 Cr PAT |
P/E (TTM to Q1 FY27) | ~41x | TTM PAT ~₹371 Cr |
P/B | ~3.5x | Net worth ~₹4,290 Cr (₹3,839 Cr + ₹450 Cr raise) |
EV/EBITDA (FY26) | ~22–24x | — |
EV/Sales (FY26) | ~2.6–2.8x | Same assumption |
Dividend yield | ~0.5% | ₹3.50 DPS |
Dividend (INR per share)
| Dividend (INR per share) | FY2023 | FY2025 | FY2026 |
|---|---|---|---|
Total DPS | 2.50 | 3.00 | 3.50 |
Credit Ratings
| Agency | Instrument | Rating | Date |
|---|---|---|---|
Crisil | Long-term bank facilities (₹4,269.75 Cr) | Crisil AA+/Stable | Reaffirmed (latest per May 2026 disclosure) |
Crisil | Commercial paper | Crisil A1+ | Same |
India Ratings | Term loan (₹300 Cr) | IND AA+/Stable | Affirmed 13 May 2026 |
India Ratings | Commercial paper (₹900 Cr) | IND A1+ | Affirmed 13 May 2026 |
ICRA | Previously AA (Positive)/A1+ (2021) | — | — |
Moody's / S&P / Fitch | Not rated | — | — |
Analyst Conclusions
Management guidance
-
PLA commercial production in Q3 FY2027 (October 2026 target), revised capex ~₹3,080 Cr.
-
Non-sugar/green revenues to reach ~50% of total within roughly three years of PLA full operation.
-
Expectation of improved cane yields from new varieties.
-
No formal FY2027 revenue or profit guidance.
Consensus expectations
Directionally, sell-side commentary emphasises: SS 2026-27 sugar realisations benefiting from tighter stocks (ICRA projects September 2026 closing stock of ~4.3 MT, about two months of consumption); distillery margins dependent on an ethanol price revision; and PLA contributing meaningfully only from FY2028 after ramp-up.
Bull case
-
PLA delivers transformational EBITDA. At the reported ~₹2,000 Cr peak revenue and ~35% margin, PLA would add ~₹700 Cr EBITDA — nearly equal to the entire FY26 group EBITDA of ₹741 Cr — from an asset 60% debt-funded and partly subsidised.
-
Sugar upcycle. The export ban, ~40% wholesale price rise since June 2026, a projected global deficit and El Niño risk point to firm realisations in SS 2026-27, lifting the core business from the trough margin of 6.96% seen in Q1 FY27.
-
Policy normalisation in ethanol. After three years of frozen juice/B-heavy prices and the CACP's recommendation for revision, any increase would flow straight to distillery margins, where BCML has 1,050 KLPD of installed capacity.
Bear case
-
Core earnings erosion. PAT has fallen two years running (₹534 Cr → ₹437 Cr → ₹378 Cr) and Q1 FY27 fell a further 14%; with SAP likely to rise again, the core business may not earn its cost of capital (ROCE ~9%).
-
PLA execution and pricing risk. A first-of-kind plant in India has already overrun capex by ~₹230 Cr; ramp-up delays or a Chinese-led PLA price decline could push returns well below the ~35% margin narrative, while incentives are utilisation-linked.
-
Valuation leaves little room. At ~38–41x earnings and ~3.5x book — about twice sector multiples — the stock discounts successful PLA execution; any slip in commissioning or disappointing initial utilisation could trigger a sharp de-rating.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Timing | What to watch |
|---|---|---|
| PLA commissioning announcement | Oct–Dec 2026 | Date of first resin, utilisation trajectory, product grades qualified |
| Q2 FY27 results | ~November 2026 | Sugar realisation, distillery margin, PLA losses |
| SS 2026-27 crushing start and UP SAP announcement | Nov 2026 – Jan 2027 | SAP level vs ₹400/qtl; recovery rates |
| Sugar export policy for SS 2026-27 | Ongoing | Extension or relaxation of the prohibition |
| Ethanol procurement price notification (ESY 2026-27) | Late 2026 | Revision for juice/B-heavy routes |
| UP Bioplastic policy subsidy disbursement | FY2027–28 | Timing and quantum of capital subsidy receipt |
| Lactogypsum plant progress | FY2027 | Capex adherence |
| NCD issuance and PLA debt drawdowns | FY2027 | Leverage vs AA+ thresholds |
| El Niño and monsoon impact | 2,027 | Cane availability for SS 2027-28 |
Analyst verdict
Balrampur Chini Mills is, in effect, two businesses wearing one ticker. The first is a scale-advantaged, conservatively financed Uttar Pradesh sugar-ethanol-power complex whose earnings are hostage to government price-setting. That business is currently in a profit downcycle: consolidated PAT has declined from ₹534 Cr in FY2024 to ₹378 Cr in FY2026, EBITDA margin fell to under 7% in Q1 FY2027, and the twin squeeze of an 8% cane price hike and a three-year freeze on ethanol procurement prices shows no sign of easing on the cost side. Operationally, BCML continues to outperform — crushing 5% more cane in a season when the state crushed 7% less — but operational excellence cannot fully offset policy-set economics.
The second business is a nascent, technologically distinctive PLA bioplastics platform that could, if management's ambitions are realised, add EBITDA comparable to the entire current group within a few years. With roughly ₹2,180 Cr already spent, Sulzer technology, renewable captive power and state subsidies, the asset is close to completion; the question is no longer whether it will be built, but how quickly it ramps and at what price PLA sells against imports.
The market has made up its mind faster than the evidence: at around ₹714, the stock trades at about 40x trailing earnings and roughly 3.5x book, double sector multiples. That valuation is defensible only if PLA commissions on time in Q3 FY2027, achieves meaningful utilisation in FY2028, and core sugar margins recover with the domestic price upcycle. The balance sheet (AA+ ratings, minimal legacy debt, fresh ₹450 Cr equity) provides genuine downside protection against financial distress, but not against de-rating.
Verdict: a high-quality operator with a credible transformation story, priced for execution. The next two to three quarters — commissioning, early utilisation, SAP and ethanol price decisions — will determine whether the premium is earned or unwound. Investors should treat PLA ramp data as the single most important monitorable.
Source list (principal)
-
BCML FY2026 audited results, press release and board outcome (15 May 2026) — chini.com, NSE/BSE
-
BCML Q1 FY2027 results, presentation, monitoring agency report and board outcome (11 Aug 2026)
-
BCML Q4 FY2026 and Q3 FY2026 investor presentations and earnings calls (via AlphaStreet, Multibagg, Investywise summaries)
-
NSE filings: credit rating updates (28 Mar 2025, 16 May 2025), auditor status (13 Jan 2024)
-
India Ratings affirmation (13 May 2026) via Investywise; FilingReader summaries of allotment (3 Jun 2026) and dividend (11 Nov 2025)
-
PTI via HDFC Sky (Q1 FY27); Business Standard (Q4 FY25; Aug 2021 buyback; Apr 2021 ICRA)
-
Chemical Weekly (12 May 2026); Swarajya (21 Aug 2026); ChiniMandi (16 Oct 2026); European Bioplastics member profile
-
ICRA Indian Sugar Sector update (May 2026); DGFT notification coverage (The Hitavada, 15 May 2026); Czarnikow analyst insights (May and July 2026)
-
Aggregators for market and ownership data: Upstox, MarketsMojo, Sharpely, Anand Rathi, Screener, Value Research, Craytheon, Kotak Neo, Equitymaster
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure / status | Background (as disclosed) |
|---|---|---|---|
Vivek Saraogi | Chairman & Managing Director | Long-standing promoter-CMD; reappointed for 5 years from 1 Apr 2027 (board approval 15 May 2026, subject to shareholders) | Promoter family; trustee of Saraogi Family Trust |
Avantika Saraogi | Whole-time Director (Executive Director) | Reappointed for 5 years from 1 Jan 2027 | Promoter family; public face of the PLA/Bioyug strategy |
Pramod Patwari | Chief Financial Officer | — | — |
Manoj Agarwal | Company Secretary & Compliance Officer | Signatory on 2024–2026 exchange filings | — |
Stefan Barot | President – Chemical Division (PLA) | Leads PLA business | Bioplastics industry background (European Bioplastics member profile) |
Praveen Gupta | Whole-time Director (as of 2023 AGM) | — | Operations |
Board of Directors
| Name | Category | Notes |
|---|---|---|
Vivek Saraogi | Executive, Promoter, Chair | Chair and MD roles combined |
Avantika Saraogi | Executive, Promoter | — |
Vartika Shukla | Non-executive Independent | Appointed additional director 11 Aug 2026 for 5 years to 10 Aug 2031, subject to shareholder approval |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
15 May 2026 | Reappointment of Vivek Saraogi (CMD) and Avantika Saraogi (ED); change-in-directorate and change-in-management filings | Leadership continuity through PLA ramp-up |
15 May 2026 | Change in auditors filing | — |
11 Aug 2026 | Vartika Shukla appointed independent director | Board refresh |
Shareholding Trend
| Holder category (%) | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|
Promoters | 42.87 | 42.86 | 42.85 | 42.85 | 42.86 |
Mutual funds | 26.09 | 25.40 | 25.24 | 25.42 | 25.54 |
Foreign institutions | 11.99 | 11.21 | 10.55 | 10.43 | 9.44 |
Other domestic institutions | 1.93 | 2.20 | 2.26 | 2.26 | — |
Retail and others | 17.13 | 18.33 | 19.10 | 19.04 | — |
Major Shareholders
| Holder | Stake (%) | Source |
|---|---|---|
Saraogi Family Trust (Vivek Saraogi, trustee) | 24.83 | MarketsMojo |
SBI Mutual Fund schemes (largest named: SBI Retirement Benefit Fund – Conservative Hybrid, as labelled) | 6.28 | MarketsMojo (label may aggregate SBI MF schemes) |
Tata Small Cap Fund | not disclosed (also a preferential allottee) | MarketsMojo; allotment filing |
ICICI Prudential MF schemes | not disclosed (preferential allottee) | Allotment filing |
Competitive Landscape
Peer Comparison FY2026
| Company | Revenue FY26 or TTM | Net profit FY26 or TTM | Net margin (%) | Market cap Sep 2026 |
|---|---|---|---|---|
Balrampur Chini Mills | 6,271 | 378 | 6.0 | 14,886 |
Triveni Engineering & Industries | 7,621 | 269 | 3.5 | 6,191 |
Shree Renuka Sugars | 9,365 | -780 | -8.2 | 5,181 |
Bajaj Hindusthan Sugar | 5,332 | 115 | 2.2 | 5,291 |
Dalmia Bharat Sugar & Industries | 3,525 | 207 | 5.7 | 3,729 |
Competitor Detail
| Growth benchmark | FY26 revenue growth (%) | FY26 PAT growth (%) |
|---|---|---|
Balrampur Chini Mills | 15.8 | -13.4 |
Triveni Engineering | 11.9 | 12.8 |



